PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 6.91 ▼ -0.23 (-3.22%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ardelyx Inc | ARDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -0.42% | 7.14 | 7.40 | 7.115 | 7.23 | 7.17 | 23:59:40 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.81 | 8.01 | 4.20 | 52.43% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,241 | 466,995 | $ 7.26 | $ 3,388,108 | 1,115,450 | 1.86 - 10.4343 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:30:26 | priorref | 4,093 | $ 7.14 | USD |
Ardelyx Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 469.87M | 65.81M | $ -91.30M | -1.62 | - | 63.59M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Ardelyx News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/04/2019 | 23:32 | PR Newswire (US) | Ardelyx Announces Pricing of Upsized Public Offering of.. |
| 12/04/2019 | 16:56 | PR Newswire (US) | Ardelyx Announces Proposed Public Offering of Common Stock |
| 12/03/2019 | 07:25 | PR Newswire (US) | Ardelyx Announces Positive Topline Results from Pivotal.. |
| 12/02/2019 | 16:01 | PR Newswire (US) | Ardelyx to Host Conference Call on December 3 to Review.. |
| 11/26/2019 | 16:00 | PR Newswire (US) | Ardelyx to Present at the Piper Jaffray 31st Annual.. |
| 11/25/2019 | 18:00 | PR Newswire (US) | Ardelyx and Kyowa Kirin Expand Partnership with Two.. |
| 11/06/2019 | 16:26 | Edgar (US Regulatory) | Quarterly Report (10-q) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.62 | 7.62 | 6.79 | 7.07 | 747,604 | -0.48 | -6.3% |
| 1 Month | 8.33 | 8.50 | 6.79 | 7.57 | 798,634 | -1.19 | -14.29% |
| 3 Months | 4.81 | 10.4343 | 4.78 | 7.17 | 946,744 | 2.33 | 48.44% |
| 6 Months | 2.59 | 10.4343 | 2.10 | 6.02 | 961,943 | 4.55 | 175.68% |
| 1 Year | 2.21 | 10.4343 | 1.86 | 5.59 | 579,742 | 4.93 | 223.08% |
| 3 Years | 14.55 | 15.40 | 1.60 | 5.66 | 491,922 | -7.41 | -50.93% |
| 5 Years | 25.9995 | 28.19 | 1.60 | 6.96 | 355,155 | -18.86 | -72.54% |
Ardelyx Description
| Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. |
